WallStSmart
PBM

Psyence Biomedical Ltd. Common Shares

NASDAQ: PBM · HEALTHCARE · BIOTECHNOLOGY

$2.98
-5.70% today

Updated 2026-07-29

Market cap
$11.02M
P/E ratio
P/S ratio
EPS (TTM)
$-12.85
Dividend yield
52W range
$2 – $75
Volume
0.1M

WallStSmart proprietary scores

26
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C
7.3
Quality
B+
3.0
Profitability
D
5.0
Valuation
C+
2/9
Piotroski F-Score
Weak
10.5
Altman Z-Score
Safe zone
Industry rank
View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target
12-Month target
Intrinsic (DCF)
Margin of safety

Price chart

Stock snapshot

Strengths
+ Altman Z 10.54 — safe zone
Risks
- Piotroski 2/9 — weak financial health
- Thin margins at 0.00%
- Negative free cash flow $-8.64M

Key financials

Revenue Net Income Free Cash Flow
Metric2023202420252026TTM
Revenue$0.00$0.00$0.00$0.00$0.00
Net income$8.01M$-51.16M$1.01M$-6.94M$-6.94M
EPS$-12.85
Free cash flow$-2153.00$-2.95M$-3.74M$-8.64M$-8.64M
Profit margin

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
PBM$11.02M264.33.05.07.3Avoid
LLY$1.02T7610.010.04.36.0Strong Buy
JNJ$615.36B574.78.54.36.0Buy
ABBV$447.53B634.08.04.75.0-78.83%Buy
UNH$391.69B627.35.54.06.0-30.51%Buy
MRK$307.25B503.38.02.75.0-62.28%Hold

Smart narrative

Psyence Biomedical Ltd. Common Shares trades at $2.98. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of 10.54, it sits in the safe zone.

Frequently asked questions

What is Psyence Biomedical Ltd. Common Shares's stock price?

Psyence Biomedical Ltd. Common Shares (PBM) trades at $2.98.

Is Psyence Biomedical Ltd. Common Shares overvalued?

Psyence Biomedical Ltd. Common Shares carries a Smart Value Score of 26/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

Altman Z-Score?

Psyence Biomedical Ltd. Common Shares's Altman Z-Score is 10.54, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio
ROE-74.30%
Beta1.68
50D MA$3.87
200D MA$35.58
Shares out0.00B
Float0.00B
Short ratio
Avg volume0.1M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years